Overview

• The U.S. Preventive Services Task Force has proposed updated guidelines allowing women aged 30 to 65 to self-collect vaginal samples for HPV testing in clinical settings every five years.
• The new self-testing option aims to increase cervical cancer screening rates, particularly among women who may avoid traditional Pap smears due to discomfort or access issues.
• Studies show HPV testing is more effective at detecting cervical cancer in women over 30 than Pap smears, though both methods remain available under the guidelines.
• Cervical cancer cases and deaths have significantly declined due to widespread screening and HPV vaccination, but disparities persist, with higher rates among low-income women and women of color.
• The draft recommendations are open for public comment until January 13, with the goal of finalizing guidelines that improve accessibility and equity in cervical cancer prevention.